Confidence in Vaccines Both Steady and Rising in U.S. Adults
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 2, 2025 -- Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by the American public, while confidence in other vaccines remains unchanged, according to the results of a new Annenberg Public Policy Center survey.
The survey, led by Kathleen Hall Jamieson and other researchers at the University of Pennsylvania, included a nationally representative sample of 1,771 U.S. adults and was conducted from Nov. 14 to 24, 2024.
More than half of U.S. adults (52 percent) think the vaccine given to pregnant individuals to protect infants from RSV is effective, up from 42 percent in October 2023, while 61 percent say the RSV vaccine is effective for adults aged 60 years and older, up from 54 percent in October 2023. In contrast, 86 percent of respondents say the measles, mumps, and rubella vaccine is safe, up from 81 percent in October 2023 and similar to August 2022 (88 percent), and 83 percent say the flu vaccine is safe, unchanged from October 2023. Less than two-thirds of respondents (65 percent) say the COVID-19 vaccine is safe, unchanged from 2023. Respondents view the seasonal flu shot as more effective at reducing the risk for getting a severe illness (75 percent) compared with the COVID-19 booster for reducing the risk for getting a severe case of the disease (55 percent). Despite belief in safety and effectiveness, only 51 percent of respondents either received the seasonal flu shot (40 percent) or say they are very likely to receive it (11 percent) or the COVID-19 booster (38 percent received it and 9 percent are very likely to).
"Despite continuing attacks on the safety and efficacy of certain vaccines by some politicians, nine in 10 respondents say it is important for parents to get their children vaccinated," according to the authors of the report.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-03 06:00
Read more
- Dementia Diagnosis Risk Higher for Stroke Survivors for Up to 20 Years
- A Number of Older Adults Report Loneliness, Social Isolation
- FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome
- Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
- Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy
- Rates of Substance Use Down for Teens in the United States
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions